Serial single-cell RNA sequencing of estrogen receptor-positive (ER + ) breast tumors from multiple patient cohorts, combined with experimental analyses, uncovers molecular mechanisms of compensatory growth signaling that drive proliferation in endocrine +/- CDK4/6 inhibitor-resistant cancer cells. Here, CDK4 is linked to cancer.